LEADER 08141nam 2200661 450 001 9910795739803321 005 20230725002838.0 010 $a981-5050-56-7 035 $a(MiAaPQ)EBC7014636 035 $a(Au-PeEL)EBL7014636 035 $a(CKB)23525871000041 035 $aEBL7014636 035 $a(AU-PeEL)EBL7014636 035 $a(EXLCZ)9923525871000041 100 $a20230626d2022 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aArtificial intelligence based cancer nanomedicine $ediagnostics, therapeutics and bioethics /$fedited by Fahima Dilnawaz and Ajit Kumar Behura 205 $aFirst edition. 210 1$aSingapore :$cBentham Science Publishers Pte. Ltd.,$d[2022] 210 4$dİ2022 215 $a1 online resource (110 pages) $cillustrations 300 $aDescription based upon print version of record. 311 08$aPrint version: Dilnawaz, Fahima Artificial Intelligence Based Cancer Nanomedicine: Diagnostics, Therapeutics and Bioethics Singapore : Bentham Science Publishers,c2022 9789815050578 320 $aIncludes bibliographical references and index. 327 $aCover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- The Need for Artificial Intelligence in Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Application of Artificial Intelligence for Designing Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- USE OF NANOMATERIALS AND AI IN PRECISION DIAGNOSTICS -- PREDICTION OF PERSONALIZED DRUG POTENCY BY NANOTECHNOLOGY -- UTILIZING COMPUTATIONAL MODELLING IN NANOTHERAPEUTICS FOR TARGETING AND PERSONALIZED DOSING -- UTILIZING AI AND NANOMATERIALS FOR DRUG DOSING AND IMPROVED THERAPEUTIC EFFICACY -- EXPLOITING THE USE OF AI AND NANOTECHNOLOGY FOR PERSONALIZED GENE THERAPY -- CONCLUSION AND FUTURE PERSPECTIVE -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence and its Application in Cancer Nanomedicine -- Sweta Mohanty1, Sarbari Acharya1 and Chandana Mohanty1,* -- INTRODUCTION -- CANCER NANOMEDICINE -- ARTIFICIAL INTELLIGENCE (AI) -- ROLE OF AI IN DRUG DISCOVERY -- APPLICATION OF AI TECHNOLOGIES IN CANCER NANOMEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence-based Diagnostic Design for Precision Cancer Nanomedicine -- Ranjita Misra1,* and Malathi Sampath2 -- INTRODUCTION -- ROLE OF NANOMEDICINES IN CANCER DIAGNOSIS -- NANOMEDICINES USED FOR CANCER DIAGNOSIS -- ARTIFICIAL INTELLIGENCE AND ITS SIGNIFICANCE -- APPLICATION OF ARTIFICIAL INTELLIGENCE TOWARDS CANCER DIAGNOSIS -- ADVANTAGE OF INTEGRATION OF ARTIFICIAL INTELLIGENCE AND NANOMEDICINES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES. 327 $aArtificial Intelligence-based Nanosensors to Compose the Patient's Cancer Biomarker Profile -- Malathi Sampath1 and Ranjita Misra2,* -- INTRODUCTION -- NANOSENSORS AND THEIR ROLE IN BIOMARKERS PROFILING -- TYPES OF NANOSENSORS -- Affinity Based Biosensors -- Catalytic Based Sensors -- Enzymes -- Microbes -- Organelles -- Tissue Samples -- OPTICAL NANOSENSORS -- ELECTROCHEMICAL SENSORS -- CHEMICAL NANOSENSORS -- DEPLOYABLE SENSOR -- ELECTROMETERS -- BIOSENSOR -- ADVANTAGES OF AMALGAMATION OF NANOSENSORS WITH ARTIFICIAL INTELLIGENCE -- FUTURE PERSPECTIVES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence as a Putative Tool for Newer Drug Development Approach in Cancer Nanomedicine -- Pooja Jain1, Sradhanjali Mohapatra1, Nazia Hassan1, Manvi Singh2, Uzma Farooq1, Mohd. Aamir Mirza1 and Zeenat Iqbal1,* -- INTRODUCTION -- CANCER -- Cancer Diagnosis and Treatment Approaches -- Cancer Nanomedicines -- ARTIFICIAL INTELLIGENCE -- Integration of AI and Nanotechnology for Cancer Therapy -- Artificial Intelligence-Driven Approach for Future Healthcare System -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENT -- REFERENCES -- Artificial Intelligence-Enabled Model for Predicting the Metastatic Potential of Cancer Cells -- Sarbari Acharya1,* and Chandana Mohanty1 -- INTRODUCTION -- CANCER METASTASIS -- DIAGNOSIS OF CANCER METASTASIS -- ARTIFICIAL INTELLIGENCE AND CANCER DETECTION -- ROLE OF AI MODELS FOR PREDICTING CANCER METASTASIS -- FUTURE PERSPECTIVES AND CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence for Cancer Nanotheranostics -- Sarbari Acharya1,* -- INTRODUCTION -- CANCER IMAGING -- THERANOSTICS AND NANOTHERANOSTICS -- ROLE OF NANOTHERANOSTICS IN CANCER MANAGEMENT. 327 $aAI IN NANOMEDICINE FOR CANCER THERAPY -- AI AND NANOTHERANOSTICS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Ethical Dimensions of Using Artificial Intelligence in Healthcare -- Ajit Kumar Behura1,* -- INTRODUCTION -- ETHICAL CONSIDERATIONS WHEN USING AI IN HEALTH CARE -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index -- Back Cover. 330 $aNanomedicine is evolving with novel drug formulations devised for multifunctional approaches towards diagnostics ad therapeutics. Nanomedicine-based drug therapy is normally explored at a fixed dose. The drug action is time-dependent, dose-dependent and patient-specific. To overcome challenges of nanomedicine testing, artificial intelligence (AI) serves as a helping tool for optimizing the drug and dose parameters. Real time conversions between these two features enables upgradation of patient data acquisition and improved design of nanomaterials. In this scenario, AI-based pattern analysis and algorithms models can greatly improve accuracy of diagnostics and therapeutics. This book gives a comprehensive explanation of the role of machine learning and artificial intelligence in cancer nanomedicine. It presents 10 chapters that cover multiple dimensions of the subject. These dimensions are:- The need of AI and ML in designing new cancer drugs- Application of AI in cancer drug design- AI-based drug delivery models for cancer drugs- Diagnostic applications of AI- Intelligent nanosensors for biomarker profiling- Predictive models for metastatic cancer- Cancer nanotheranostics- Ethics of AI in medicine Contributions have been made by 16 researchers who are experts in pharmacology and drug design. The contents of the book bridge knowledge gaps between the fields of biomedical engineering, pharmacology and clinical medicine, with a focus on cancer treatment. The book serves as a reference for scholars learning about cancer diagnostics and therapeutics. Biomedical engineers who are involved in healthcare projects will also find the concepts and techniques highlighted in the book informative for understanding modern computer-based approaches used to solve clinical problems. 606 $aArtificial intelligence$xMedical applications 606 $aCancer$xTreatment 606 $aDrug delivery systems 606 $aNanomedicine 606 $aBioethical Issues 606 $aNanomedicine 606 $aArtificial Intelligence 606 $aNeoplasms$xtherapy 615 0$aArtificial intelligence$xMedical applications. 615 0$aCancer$xTreatment. 615 0$aDrug delivery systems. 615 0$aNanomedicine. 615 2$aBioethical Issues. 615 2$aNanomedicine. 615 2$aArtificial Intelligence. 615 2$aNeoplasms$xtherapy. 676 $a610.285 702 $aDilnawaz$b Fahima 702 $aBehura$b Ajit Kumar 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910795739803321 996 $aArtificial intelligence based cancer nanomedicine$93807231 997 $aUNINA